The Kansas Board of Healing Arts and Board of Pharmacy published a joint statement Wednesday highlighting concerns with ...

Kansas health regulators issued a joint warning on Wednesday, Feb. 25, saying many retail IV therapy clinics are likely ...

The Kansas Board of Healing Arts along with the Board of Pharmacy released a joint statement regarding retail IV therapy on Wednesday. The statement comes in response to ...

Before the infusion was complete, she died of sudden cardiac arrest. An autopsy failed to find a cause of her death, but experts were concerned that the potassium included in the hydration might have ...

Approval expands low-dose MRI contrast options for the youngest patients and reflects a positive benefit–risk profile of ...

Rybrevant Faspro is a subcutaneous co-formulation of amivantamab, a bispecific EGFR-directed and MET receptor-directed antibody, and hyaluronidase.

An investigational stent retriever device delivered successful revascularization in more than 85% of patients with primary distal vessel occlusion ischemic stroke at 24 hours, researchers reported at ...

The company maintained its mid-single-digit growth guidance for consumables and systems, consistent with the prior quarter.

In the following situations, you can avail doctor-at-home services in Dubai. Families with children for fever, flu, and infection at home, minor injuries, allergies, and stomach upsets. Elderly or ...

The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.

The FDA has approved a monthly dosing schedule for subcutaneous amivantamab in NSCLC following the first 4 weeks of treatment ...

FDA approves monthly subcutaneous amivantamab plus lazertinib for EGFR-mutated advanced NSCLC, cutting clinic time and ...